By encouraging the ubiquitination and degradation of HER2, Xia Li worked out a design based on the chimeric ubiquitin ligase of CBL to downregulate HER2, which in turn prevented the proliferation of tumor cells (Li et al., 2007). The gene discussed is ERBB2; the disease is neoplasm.